| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF470-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF801-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB801-SP | |||
| Carrier Free | MAB801-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-16041SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB470-SP | |||
| Carrier Free | MAB470-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4701-SP | |||
| Carrier Free | MAB4701-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44241 | |||
| BSA Free | NBP3-07988-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12223-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12222-0.025mg | |||
![Western Blot: CXCL13/BLC/BCA-1 Antibody [NBP2-16041] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with BCA1 antibody [N3C3] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-Western-Blot-NBP2-16041-img0017.jpg "Western Blot: CXCL13/BLC/BCA-1 Antibody [NBP2-16041] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with BCA1 antibody [N3C3] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunocytochemistry/Immunofluorescence: CXCL13/BLC/BCA-1 Antibody [NBP2-16041] - HepG2 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton X-100. The cells were incubated with anti-CXCL13 at 5 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-16041-img0019.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody - BSA Free [NBP2-16041] - Human breast cancer tissue stained for CXCL13/BLC/BCA-1 (green) and counterstained with DAPI (blue). Alexa Fluor 488 version of antibody used (NBP2-16041AF488). Image from verified customer review.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NBP2-16041-img0020.jpg)
![Western Blot: CXCL13/BLC/BCA-1 Antibody [NBP2-16041] - Non-transfected (-) and transfected (+) 293T whole cell extracts (60 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with BCA1 antibody [N3C3] diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-Western-Blot-NBP2-16041-img0015.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody [NBP2-16041] - Analysis of a FFPE tissue section of human esophageal carcinoma using 1:300 dilution of CXCL13 antibody (NBP2-16041). The signal was developed using HRP-DAB method which followed counterstaining of the cells with hematoxylin.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-Immunohistochemistry-Paraffin-NBP2-16041-img0018.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Analysis in human tonsil and skeletal muscle tissues using NBP3-07988 antibody. Corresponding CXCL13/BLC/BCA-1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-CL10543-Immunohistochemistry-Paraffin-NBP3-07988-img0001.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Analysis in human tonsil and skeletal muscle tissues using NBP3-07988 antibody. Corresponding CXCL13/BLC/BCA-1 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-CL10543-Immunohistochemistry-Paraffin-NBP3-07988-img0004.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-CL10543-Immunohistochemistry-Paraffin-NBP3-07988-img0002.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-CL10543-Immunohistochemistry-Paraffin-NBP3-07988-img0003.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (CL10543) [NBP3-07988] - Staining of human tonsil shows moderate positivity in secretion in germinal center.](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-CL10543-Immunohistochemistry-Paraffin-NBP3-07988-img0005.jpg)
![Western Blot: CXCL13/BLC/BCA-1 Antibody (PSH04-34) [NBP3-32234] - Western blot analysis of CXCL13/BLC/BCA-1 on different lysates with Rabbit anti-CXCL13/BLC/BCA-1 antibody (NBP3-32234) at 1/1,000 dilution. Lane 1: 293T-NT cell lysate Lane 2: 293T-OE-CXCL13 cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 13 kDa Observed band size: 12/13 kDa Exposure time: 30 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32234) at 1/1,000 dilution was used in 5% NFDM/TBST at 4C overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32234_rabbit-cxcl13-blc-bca-1-mab-psh04-34-27820241631655.jpg "Western Blot: CXCL13/BLC/BCA-1 Antibody (PSH04-34) [NBP3-32234] - Western blot analysis of CXCL13/BLC/BCA-1 on different lysates with Rabbit anti-CXCL13/BLC/BCA-1 antibody (NBP3-32234) at 1/1,000 dilution. Lane 1: 293T-NT cell lysate Lane 2: 293T-OE-CXCL13 cell lysate Lysates/proteins at 15 ug/Lane. Predicted band size: 13 kDa Observed band size: 12/13 kDa Exposure time: 30 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32234) at 1/1,000 dilution was used in 5% NFDM/TBST at 4C overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.")
![Immunohistochemistry: CXCL13/BLC/BCA-1 Antibody (PSH04-34) [NBP3-32234] - Immunohistochemical analysis of paraffin-embedded human appendix tissue with Rabbit anti-CXCL13/BLC/BCA-1 antibody (NBP3-32234) at 1/100 dilution. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32234) at 1/100 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/nbp3-32234_rabbit-cxcl13-blc-bca-1-mab-psh04-34-298202414333650.jpg)
![Immunocytochemistry/ Immunofluorescence: CXCL13/BLC/BCA-1 Antibody (PSH04-34) [NBP3-32234] - Immunocytochemistry analysis of HeLa transfacted with or without CXCL13/BLC/BCA-1 cells labeling CXCL13/BLC/BCA-1 with Rabbit anti-CXCL13/BLC/BCA-1/BLC/BCA-1 antibody (NBP3-32234) at 1/400 dilution. Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CXCL13 antibody (NBP3-32234) at 1/400 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594) was used as the secondary antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/nbp3-32234_rabbit-cxcl13-blc-bca-1-mab-psh04-34-29202410334051.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (HL2172) - Azide and BSA Free [NBP3-25379] - BCA1 antibody [HL2172] detects BCA1 protein by immunohistochemical analysis. Sample: Paraffin-embedded human Clear Cell Renal Cell Carcinoma (ccRCC). BCA1 stained by BCA1 antibody [HL2172] (NBP3-25379) diluted at 1:100. Antigen Retrieval: Tris-EDTA buffer, pH 8.0, 15 min](http://images.novusbio.com/fullsize/nbp3-25379_rabbit-cxcl13-blc-bca-1-mab-hl2172-azide-and-bsa-free-2120249383135.jpg "Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (HL2172) - Azide and BSA Free [NBP3-25379] - BCA1 antibody [HL2172] detects BCA1 protein by immunohistochemical analysis. Sample: Paraffin-embedded human Clear Cell Renal Cell Carcinoma (ccRCC). BCA1 stained by BCA1 antibody [HL2172] (NBP3-25379) diluted at 1:100. Antigen Retrieval: Tris-EDTA buffer, pH 8.0, 15 min")
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (HL2172) - Azide and BSA Free [NBP3-25379] - BCA1 antibody [HL2172] detects secreted BCA1 protein by immunohistochemical analysis. Sample: Paraffin-embedded human spleen. BCA1 stained by BCA1 antibody [HL2172] (NBP3-25379) diluted at 1:100. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/nbp3-25379_rabbit-cxcl13-blc-bca-1-mab-hl2172-azide-and-bsa-free-2120249371556.jpg)
![Western Blot: CXCL13/BLC/BCA-1 Antibody (HL2172) - Azide and BSA Free [NBP3-25379] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with BCA1 antibody [HL2172] (NBP3-25379) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-25379_rabbit-cxcl13-blc-bca-1-mab-hl2172-azide-and-bsa-free-2120249374938.jpg)
![Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (RM0205-19N1) [NBP2-12223] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12223](http://images.novusbio.com/fullsize/CXCL13-BLC-BCA-1-Antibody-RM0205-19N1-Immunohistochemistry-Paraffin-NBP2-12223-img0001.jpg "Immunohistochemistry-Paraffin: CXCL13/BLC/BCA-1 Antibody (RM0205-19N1) [NBP2-12223] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12223")